Author： Kaplan G.A. Salonen J.T. Julkunen J. Kauhanen J. Salonen R.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 221-221
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disease progression and neuroscience
By Holford Nick
Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. :
Access to resources
Recommend
Targeting the Progression of Parkinson's Disease
Current Neuropharmacology, Vol. 7, Iss. 1, 2009-03 ,pp. :
Levodopa/carbidopa and Parkinson's disease progression
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
Slowing progression in Alzheimer's disease: potential of `Cerebrolysin'
Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. :